Antibodies, Monoclonal, Murine-Derived
Concept
Vocabulary Service
Overview
subject area of
-
A Canadian phase II study evaluating the efficacy of rituximab in the management of patients with relapsed/refractory thrombotic thrombocytopenic purpura Conferences
-
A phase‐II sequential case‐series study of all patients presenting to four plasma exchange centres with presumed relapsed/refractory thrombotic thrombocytopenic purpura treated with rituximab Journal Articles
-
A pilot randomized trial of adjuvant rituximab or placebo for nonsplenectomized patients with immune thrombocytopenia Journal Articles
-
A randomized, open‐label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relapsed chronic lymphocytic leukaemia Journal Articles
-
Application of the systematic review and bibliometric network analysis (SeBriNA) methodology contextualizes evidence. Part 2: rituximab for non-Hodgkin's lymphoma Journal Articles
-
Autologous Stem Cell Transplantation in Follicular Lymphoma: a Systematic Review and Meta-analysis Journal Articles
-
Autologous Transplantation as Consolidation for Aggressive Non-Hodgkin's Lymphoma Journal Articles
-
Autologous and Allogeneic Stem-Cell Transplantation for Transformed Follicular Lymphoma: A Report of the Canadian Blood and Marrow Transplant Group Journal Articles
-
Bortezomib Added to R-CVP Is Safe and Effective for Previously Untreated Advanced-Stage Follicular Lymphoma: A Phase II Study by the National Cancer Institute of Canada Clinical Trials Group Journal Articles
-
CSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common β chain of the IL-3, GM-CSF and IL-5 receptors Journal Articles
-
Childhood Immune Thrombocytopenia: A Changing Therapeutic Landscape Journal Articles
-
Conference abstracts of a new oncology drug do not always lead to full publication: Proceed with caution Journal Articles
-
Current Options for the Treatment of Idiopathic Thrombocytopenic Purpura Journal Articles
-
Effect of the addition of rituximab to salvage chemotherapy prior to autologous stem cell transplant in aggressive CD20+ lymphoma: a cohort comparison from the NCIC Clinical Trials Group Study LY.12* Journal Articles
-
Favorable Outcomes from Allogeneic and Autologous Stem Cell Transplantation for Patients with Transformed Nonfollicular Indolent Lymphoma Journal Articles
-
First-Line Therapy, Autologous Stem-Cell Transplantation, and Post-Transplantation Maintenance in the Management of Newly Diagnosed Mantle Cell Lymphoma Journal Articles
-
Hepatitis B, Rituximab, Screening, and Prophylaxis: Effectiveness and Cost Effectiveness Journal Articles
-
Immunotherapies in Dermatologic Disorders Journal Articles
-
Immunotherapy with rituximab during peripheral blood stem cell transplantation for non-Hodgkin's lymphoma Journal Articles
-
Life‐threatening hemolytic anemia due to an autoanti‐Pr cold agglutinin: evidence that glycophorin A antibodies may induce lipid bilayer exposure and cation permeability independent of agglutination Journal Articles
-
Long-term outcomes to fludarabine and rituximab in Waldenström macroglobulinemia Journal Articles
-
Misleading hepatitis B test results due to intravenous immunoglobulin administration: implications for a clinical trial of rituximab in immune thrombocytopenia Journal Articles
-
Mixed Variant Multicentric Castleman Disease Treated With Rituximab: Case Report Journal Articles
-
Monoclonal gammopathy and glomerulopathy associated with chronic lymphocytic leukemia Journal Articles
-
New treatments for idiopathic thrombocytopenic purpura: rethinking old hypotheses Journal Articles
-
Outcomes of MYC‐associated lymphomas after R‐CHOP with and without consolidative autologous stem cell transplant: subset analysis of randomized trial intergroup SWOG S9704 Journal Articles
-
Phase II multicenter study of oblimersen sodium, a Bcl‐2 antisense oligonucleotide, in combination with rituximab in patients with recurrent B‐cell non‐Hodgkin lymphoma Journal Articles
-
Positioning new treatments in the management of immune thrombocytopenia Journal Articles
-
Pure red cell aplasia complicating B cell small lymphocytic lymphoma: a case report Journal Articles
-
Risk infection to spare bleeding? The quandary of splenectomy for immune thrombocytopenia Journal Articles
-
Rituximab in lymphoma: A systematic review and consensus practice guideline from Cancer Care Ontario Journal Articles
-
Rituximab maintenance for relapsed refractory thrombotic thrombocytopenic purpura Journal Articles
-
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis Journal Articles
-
Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial Journal Articles
-
Successful treatment of multiply relapsed lymphoma with rituximab as a single agent Journal Articles
-
Systematic Review: Efficacy and Safety of Rituximab for Adults with Idiopathic Thrombocytopenic Purpura Journal Articles
-
The Completeness of Reporting (CORE) index identifies important deficiencies in observational study conference abstracts Journal Articles
-
The effect of rituximab on humoral and cell mediated immunity and infection in the treatment of autoimmune diseases Journal Articles
-
The effect of rituximab on vaccine responses in patients with immune thrombocytopenia Journal Articles
-
The role of rituximab in the management of patients with acquired thrombotic thrombocytopenic purpura Journal Articles
-
Thrombotic thrombocytopenic purpura in pediatric patients. Journal Articles
-
Thrombotic thrombocytopenic purpura: 2008 Update Journal Articles
-
Treatment Strategies in Elderly Patients with Aggressive Histology Lymphoma Journal Articles
-
Tubular Lesions Predict Renal Outcome in Antineutrophil Cytoplasmic Antibody–Associated Glomerulonephritis after Rituximab Therapy Journal Articles
-
Use of anti‐CD20 antibody in the treatment of post‐transplant glomerulonephritis Journal Articles